CHRNA3 and lung carcinoma: The difference in CHRNA3 rs1051730 and CHRNB4 rs6495309 combination was associated with lung cancer risk in a dose-dependent fashion in discovery (adjusted trend test P = 1.55 × 10−24) and replication (adjusted trend test P = 4.80 × 10−50).